Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Significant Decline in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the target of a significant decrease in short interest in the month of August. As of August 31st, there was short interest totaling 58,624 shares, a decrease of 46.1% from the August 15th total of 108,801 shares. Based on an average trading volume of 4,225,824 shares, the days-to-cover ratio is currently 0.0 days. Currently, 6.4% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the company. Zacks Research upgraded Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. Weiss Ratings raised Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research report on Tuesday, July 28th. Finally, Wall Street Zen cut Autonomix Medical from a “sell” rating to a “strong sell” rating in a research note on Monday. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $42.00.

Get Autonomix Medical alerts:

View Our Latest Analysis on AMIX

Autonomix Medical Stock Performance

Shares of NASDAQ:AMIX traded down $0.12 during trading hours on Tuesday, reaching $4.21. The stock had a trading volume of 127,436 shares, compared to its average volume of 1,643,072. Autonomix Medical has a 1 year low of $2.44 and a 1 year high of $32.55. The firm’s 50 day moving average is $5.87 and its 200-day moving average is $7.29. The stock has a market capitalization of $4.09 million, a price-to-earnings ratio of -0.10 and a beta of -1.00.

Autonomix Medical (NASDAQ:AMIX – Get Free Report) last released its quarterly earnings data on Wednesday, August 12th. The company reported ($5.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($6.40) by $1.38. Analysts forecast that Autonomix Medical will post -20.17 EPS for the current year.

Autonomix Medical Company Profile

(Get Free Report)

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

Featured Stories

• Five stocks we like better than Autonomix Medical
• Running on Empty: 3 Energy Plays for Europe’s Deep Freeze
• 3 Healthcare Stocks for 3 Stages of Life
• Curaleaf Tries To Roll Up Aurora In a Hostile Cannabis Bid
• MarketBeat’s Most Downgraded Stocks in Q3: 2 Look Cheap, 1 Looks Risky

Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.